Document is current
Any future updates will be listed below
-
Authors
Tatematsu, Miho
Inaguma, Daijo https://orcid.org/0000-0002-3977-5933
Yamada, Takumi
Sakamoto, Izumi
Sakakibara, Masako
-
Funding
Funding for this research was provided by:
Aichi Kidney Foundation
- License Information
-
More Information
Article History
Received: 12 March 2020
Accepted: 6 May 2020
First Online: 26 May 2020
Compliance with ethical standards
:
: DI has received lecture fees from Ono Pharmaceutical Co., Ltd, Kyowa Hakko Kirin Co., Ltd, and Torii Pharmaceutical Co., Ltd.
: This study was conducted in accordance with the ethical guidelines for clinical research by the Japanese Ministry of Health, Labor, and Welfare (created on July 30, 2003; full revision, December 28, 2004; full revision, July 31, 2008) and the Helsinki Declaration (revised 2013) and was approved by the clinical research ethics committees at each AICOPP group facility (approval number 20110823–3). The participants received oral and written explanations of the purpose of the study and provided a written consent. The trial registration number of the study is UMIN 7096, registered on January 18, 2012.
